In conclusion, we systematically confirmed the inhibitory effect of TRAF6 on the RIPK1-RIPK3-MLKL signaling axis in vivo and promoted the growth of colorectal cancer cells in a xenograft tumor model. This evidence concerns the gene RIPK1 and neoplasm.